Blue Capital Inc
PFE icon

Blue Capital Inc’s Pfizer PFE Stock Holding History

Blue Capital Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$344K Buy
12,050
+450
+4% +$12K 0.21% 99
2026
Q2 		$279K Buy
11,600
+1,866
+19% +$48.8K 0.18% 100
2026
Q1 		$273K Buy
9,734
+1,068
+12% +$28.4K 0.18% 88
2025
Q4 		$216K Buy
+8,666
New +$219K 0.15% 83
2024
Q4 		$595K Buy
+22,444
New +$609K 0.42% 66

Other funds holding PFE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Blue Capital Inc's PFE Position: Q3 2026 in Review

Blue Capital Inc increased its Pfizer (PFE) stake by 3.9% in Q3 2026, buying an estimated $12K and bringing the position to 12,050 shares worth $344K. The position accounts for 0.21% of the portfolio, ranked #99.

Blue Capital Inc first reported a position in PFE in Q4 2024 and has held it in 5 quarters since. The position peaked at $595K in Q4 2024. 1,743 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Blue Capital Inc held 12,050 shares of Pfizer worth $344K as of Q3 2026.
  • Blue Capital Inc bought 450 Pfizer shares in Q3 2026, an estimated $12K.
  • Pfizer made up 0.21% of Blue Capital Inc's portfolio in Q3 2026, its #99 holding.
  • Blue Capital Inc first reported a position in Pfizer in Q4 2024 and has held it in 5 quarters since.
  • Blue Capital Inc's Pfizer position peaked at $595K in Q4 2024.
  • 1,743 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Blue Capital Inc's 13F filing for Q3 2026, filed 13 Oct 2026.